New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.
The Advertising Standards Authority’s (ASA) Committee of Advertising Practice (CAP) has issued an enforcement notice against the advertising of a hay fever treatment injection in the UK.
The Committee of Advertising Practice (CAP) has released a new series of CAP Bitesize instructional videos specifically for aesthetics advertising rules.
The Advertising Standards Authority (ASA) has issued a ruling against aesthetic treatment comparison site Glowday, after it posted content advertising botulinum toxin to the public.
Three weight loss injection clinics have had their adverts banned by the ASA after promoting the prescription-only weight loss medicine liraglutide.
The Advertising Standards Authority (ASA) has issued a ruling against an aesthetic clinic after it posted promotional material about a celebrity botulinum toxin procedure.
The Advertising Standards Authority (ASA) has upheld two complaints issued by the Joint Council of Cosmetic Practitioners (JCCP) against Secret Surgery Ltd.
The Advertising Standards Authority (ASA) has issued a ruling against an online supplement provider based in Leeds after it advertised prescription-only hair loss medication to the public.
The Committees of Advertising Practice (CAP) from the Advertising Standards Authority (ASA) has issued updated guidance on how influencers are able to promote products and services on social media.
The Advertising Standards Authority (ASA) has issued a ruling against an aesthetic and wellness clinic following longevity claims in advertisements.